{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:29:51Z","timestamp":1772886591619,"version":"3.50.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"17-18","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.11.038","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T11:45:16Z","timestamp":1071315916000},"page":"2209-2220","source":"Crossref","is-referenced-by-count":142,"title":["Pneumococcal vaccines: an update on current strategies"],"prefix":"10.1016","volume":"22","author":[{"given":"D","family":"Bogaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.W.M","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.V","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C","family":"R\u00fcmke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7\u20138","key":"10.1016\/j.vaccine.2003.11.038_BIB1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0264-410X(99)00277-7","article-title":"Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation","volume":"18","author":"Jaffar","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00006454-199701000-00016","article-title":"Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpedi.153.5.495","article-title":"Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group","volume":"153","author":"Kellner","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"26","key":"10.1016\/j.vaccine.2003.11.038_BIB4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199806253382601","article-title":"An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents","volume":"338","author":"Nuorti","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00006454-199906000-00008","article-title":"Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group","volume":"18","author":"Principi","year":"1999","journal-title":"Pediatr Infect Dis. J."},{"issue":"3\/4","key":"10.1016\/j.vaccine.2003.11.038_BIB6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1574-695X.1999.tb01389.x","article-title":"Respiratory viral infection predisposing for bacterial disease: a concise review","volume":"26","author":"Hament","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2003.11.038_BIB7","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0264-410X(99)00112-7","article-title":"Strategies for the control of pneumococcal diseases","volume":"17","author":"Mulholland","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/arrd.1986.134.5.1040","article-title":"Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A\/PR8 virus","volume":"134","author":"Plotkowski","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2003.11.038_BIB9","doi-asserted-by":"crossref","first-page":"S338","DOI":"10.1086\/513841","article-title":"The pneumococcus at the millennium: not down, not out","volume":"179","author":"Austrian","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB10","first-page":"833","article-title":"Versuche uber Immunisierung und Heilung bei der Pneumokokkeninfection","volume":"28","author":"Klemperer","year":"1891","journal-title":"Berl Klin Wochenstr"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB11","first-page":"198","article-title":"A brief history of the pneumococcus in biomedical research","volume":"14","author":"Watson","year":"1999","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.vaccine.2003.11.038_BIB12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/38.2.131","article-title":"Biologic significance of the soluble specific substance of pneumococci","volume":"38","author":"Felton","year":"1926","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2105\/AJPH.28.3.293","article-title":"A study of a type I pneumococcus epidemicat the state hospital in Worcester, MA","volume":"28","author":"Smillie","year":"1938","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinids\/3.2.183","article-title":"Pneumococcus: the first one hundred years","volume":"3","author":"Austrian","year":"1981","journal-title":"Rev. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.vaccine.2003.11.038_BIB15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/clinids\/3.Supplement_1.S1","article-title":"Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention","volume":"3","author":"Austrian","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB17","first-page":"141","article-title":"[Problems of resistance in Streptococcus pneumoniae] Resistentieproblemen bij Streptococcus pneumoniae","volume":"140","author":"Meis","year":"1996","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"8046","key":"10.1016\/j.vaccine.2003.11.038_BIB18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(77)92892-6","article-title":"Streptococcus pneumoniae resistant to penicillin and chloramphenicol","volume":"2","author":"Appelbaum","year":"1977","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.vaccine.2003.11.038_BIB19","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/S0264-410X(00)00079-7","article-title":"Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study","volume":"18","author":"Kroon","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.038_BIB20","unstructured":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997, 46(RR-8), 1\u201324."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/clinids\/14.1.251","article-title":"Mechanisms of host defense against infection with Streptococcus pneumoniae","volume":"14","author":"Bruyn","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.mi.47.100193.000513","article-title":"Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins","volume":"47","author":"Paton","year":"1993","journal-title":"Annu Rev Microbiol"},{"issue":"14\u201315","key":"10.1016\/j.vaccine.2003.11.038_BIB23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0264-410X(98)00098-X","article-title":"Infant B cell responses to polysaccharide determinants","volume":"16","author":"Rijkers","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.038_BIB24","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/IAI.67.11.5979-5984.1999","article-title":"Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination","volume":"67","author":"Rubins","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00006454-198601000-00009","article-title":"First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants","volume":"5","author":"Koskela","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2003.11.038_BIB26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0264-410X(99)00240-6","article-title":"Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations","volume":"18","author":"Kroon","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006454-198601000-00008","article-title":"Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children","volume":"5","author":"Leinonen","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006454-199605000-00009","article-title":"Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines","volume":"15","author":"O\u2019Brien","year":"1996","journal-title":"Pediatr Infect. Dis. J."},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2003.11.038_BIB29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1542\/peds.103.5.1035","article-title":"Pneumococcal vaccine: an update","volume":"103","author":"Wadwa","year":"1999","journal-title":"Pediatrics"},{"issue":"13\/14","key":"10.1016\/j.vaccine.2003.11.038_BIB30","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0264-410X(98)00435-6","article-title":"The burden of pneumococcal disease: the role of conjugate vaccines","volume":"17","author":"Poland","year":"1999","journal-title":"Vaccine"},{"issue":"1A","key":"10.1016\/j.vaccine.2003.11.038_BIB31","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1016\/S0002-9343(99)00105-9","article-title":"Pneumococcal vaccines: history, current status, and future directions","volume":"107","author":"Butler","year":"1999","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/520272","article-title":"Pneumococcal vaccination in the United States and 20 other developed countries, 1981\u20131996","volume":"26","author":"Fedson","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB33","unstructured":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49(RR-9), 1\u201335."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/173.1.256","article-title":"Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin\u2019s disease","volume":"173","author":"Chan","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2003.11.038_BIB35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/00006454-199712000-00007","article-title":"A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children","volume":"16","author":"Obaro","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1086\/314705","article-title":"Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta","volume":"179","author":"Breukels","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2003.11.038_BIB37","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1093\/clinids\/11.Supplement_3.S598","article-title":"Pneumococcal polysaccharide vaccines","volume":"11","author":"Austrian","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1086\/313925","article-title":"Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children","volume":"31","author":"Madhi","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-132-3-200002010-00003","article-title":"Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California","volume":"132","author":"Nuorti","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/00365549850161160","article-title":"Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection","volume":"30","author":"Nielsen","year":"1998","journal-title":"Scand J. Infect. Dis."},{"issue":"9221","key":"10.1016\/j.vaccine.2003.11.038_BIB41","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006454-200003000-00001","article-title":"The pneumococcal conjugate vaccine arrives: a big win for kids","volume":"19","author":"Klein","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.038_BIB43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00006454-199808000-00005","article-title":"Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine","volume":"17","author":"Sorensen","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"8677","key":"10.1016\/j.vaccine.2003.11.038_BIB44","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(89)92033-3","article-title":"Effect of priming with carrier on response to conjugate vaccine","volume":"2","author":"Di John","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0165-2478(91)90036-A","article-title":"Pneumococcal conjugate vaccines","volume":"30","author":"Peeters","year":"1991","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006454-199602000-00009","article-title":"Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants","volume":"15","author":"Ahman","year":"1996","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.038_BIB47","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"15","key":"10.1016\/j.vaccine.2003.11.038_BIB49","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/S0264-410X(02)00681-3","article-title":"Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy","volume":"21","author":"Pelton","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB50","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/adc.88.3.211","article-title":"Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy","volume":"88","author":"Lakshman","year":"2003","journal-title":"Arch. Dis. Child"},{"issue":"7","key":"10.1016\/j.vaccine.2003.11.038_BIB55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006454-199909000-00005","article-title":"Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies","volume":"18","author":"Nieminen","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.038_BIB58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr. Infect. Dis."},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB59","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00006454-199809000-00015","article-title":"Pneumococcal vaccines for children: an update","volume":"17","author":"Daum","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB60","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(03)13772-5","article-title":"Effect of pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media","volume":"361","author":"Veenhoven","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.11.038_BIB61","unstructured":"Kilpi T, Palmu A, Jokinen J, K\u00e4hty H, M\u00e4kela. Efficacy of conjugate vaccine against acute otitis media (AOM)\u2014Finnish Experience. In: Program and Abstracts of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases, Anchorage; 5\u20138 May 2002. p. 110 (abstract)."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB62","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/infdis\/142.6.923","article-title":"Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life","volume":"142","author":"Gray","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB63","unstructured":"Veenhoven R. Impact of combined pneumococcal conjugate and polysaccharide vaccination on nasopharyngeal carriage in children with recurrent acute otitis media: Program and Abstracts of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases, Anchorage; 5\u20138 May 2002."},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB64","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine","volume":"180","author":"Mbelle","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB65","unstructured":"Hsu K, Pelton D, Heisey-Grove S, Hashemi J, Klein J, Health a.M.o.t.M.D.o.P. Conjugate vaccine era serotype-specific surveillance for invasive pneumococcal disease in massachusetts children: Program and Abstracts of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases, Giardini Naxos; 9\u201311 April 2003."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB66","unstructured":"Nohynek HM, Kilpi TM, Nuorti JP, et al. Recommending use of pneumococcal conjugate vaccine for children in Finland based on scientific evidence and cost effectiveness analysis: Program and Abstracts of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases, Giardini Naxos; 9\u201311 April 2003."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB67","unstructured":"Fara GM. Pneumococcal conjugate vaccine immunization: targeting at-risk groups or universal vaccination? Pros and cons: Program and Abstracts of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases, Giardini Naxos; 9\u201311 April 2003."},{"key":"10.1016\/j.vaccine.2003.11.038_BIB68","unstructured":"Dagan R, Givon N, Yagupsky P, et al. Effect of a 9-valent pneumococcal vaccine conjugated to CRM 197 (PnCRM9) on nasopharyngeal carriage of vaccine type and non-vaccine type Streptococcus pneumoniae (Pnc) strains among day care attendees (abstract G-552). Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, 24\u201327 September 1998. Washington, DC: American Society for Microbiology; 1998."},{"issue":"9022","key":"10.1016\/j.vaccine.2003.11.038_BIB69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"Obaro","year":"1996","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2003.11.038_BIB70","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0264-410X(00)00285-1","article-title":"The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae","volume":"19","author":"Briles","year":"2000","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB71","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1128\/IAI.67.9.4517-4524.1999","article-title":"Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H","volume":"67","author":"Neeleman","year":"1999","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB72","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/IAI.67.9.4720-4724.1999","article-title":"Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae","volume":"67","author":"Tu","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB73","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/jb.174.2.601-609.1992","article-title":"Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis","volume":"174","author":"Yother","year":"1992","journal-title":"J. Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB74","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/jb.174.2.610-618.1992","article-title":"Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene","volume":"174","author":"Yother","year":"1992","journal-title":"J. Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CMR.11.4.645","article-title":"Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)","volume":"11","author":"Briles","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"17","key":"10.1016\/j.vaccine.2003.11.038_BIB76","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0264-410X(99)00530-7","article-title":"Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules","volume":"18","author":"Nabors","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB77","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-695X.2001.tb00517.x","article-title":"Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates","volume":"31","author":"Kolberg","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB78","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/513980","article-title":"Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae","volume":"175","author":"Wu","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB79","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/IAI.68.5.3028-3033.2000","article-title":"Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae","volume":"68","author":"Ogunniyi","year":"2000","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB80","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0264-410X(96)82948-3","article-title":"PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice","volume":"14","author":"Briles","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB81","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/IAI.70.4.1739-1749.2002","article-title":"Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine","volume":"70","author":"Kang","year":"2002","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.038_BIB82","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/IAI.69.11.6718-6724.2001","article-title":"Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection","volume":"69","author":"Arulanandam","year":"2001","journal-title":"Infect Immun"},{"issue":"16","key":"10.1016\/j.vaccine.2003.11.038_BIB83","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0264-410X(99)00511-3","article-title":"The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection","volume":"18","author":"Briles","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB84","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"Briles","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB85","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB86","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2958.1997.5111879.x","article-title":"Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases","volume":"25","author":"Dintilhac","year":"1997","journal-title":"Mol. Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB87","first-page":"246","article-title":"Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies","volume":"10","author":"Romero-Steiner","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.038_BIB88","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1128\/IAI.70.10.5589-5595.2002","article-title":"Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice","volume":"70","author":"Gor","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/338928","article-title":"Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a","volume":"185","author":"Johnson","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB90","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/IAI.70.3.1143-1149.2002","article-title":"Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres","volume":"70","author":"Seo","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB91","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1128\/IAI.68.3.1557-1562.2000","article-title":"Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency","volume":"68","author":"Hirst","year":"2000","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB92","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.70.6.2886-2890.2002","article-title":"Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type","volume":"70","author":"Kadioglu","year":"2002","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2003.11.038_BIB93","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1128\/IAI.70.11.6504-6508.2002","article-title":"Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis","volume":"70","author":"Wellmer","year":"2002","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.038_BIB94","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/IAI.57.8.2324-2330.1989","article-title":"Contribution of autolysin to virulence of Streptococcus pneumoniae","volume":"57","author":"Berry","year":"1989","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0882-4010(88)90007-1","article-title":"Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae","volume":"5","author":"Lock","year":"1988","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB96","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.40.2.548-552.1983","article-title":"Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae","volume":"40","author":"Paton","year":"1983","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2003.11.038_BIB97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-1119(01)00896-4","article-title":"Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae","volume":"284","author":"Iannelli","year":"2002","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB98","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2958.1997.mmi494.x","article-title":"Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae","volume":"25","author":"Rosenow","year":"1997","journal-title":"Mol. Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.038_BIB99","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/IAI.69.10.5997-6003.2001","article-title":"Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA","volume":"69","author":"Ogunniyi","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2003.11.038_BIB101","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/IAI.68.7.4180-4188.2000","article-title":"The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses","volume":"68","author":"Overweg","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB102","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/IAI.68.2.921-924.2000","article-title":"Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model","volume":"68","author":"Tong","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2003.11.038_BIB103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/IAI.68.1.133-140.2000","article-title":"Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins","volume":"68","author":"Berry","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0882-4010(92)90116-6","article-title":"Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae","volume":"12","author":"Lock","year":"1992","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MMBR.65.2.187-207.2001","article-title":"Pneumococcal virulence factors: structure and function","volume":"65","author":"Jedrzejas","year":"2001","journal-title":"Microbiol Mol. Biol. Rev."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.038_BIB106","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"Hollingshead","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2003.11.038_BIB107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2958.2000.01718.x","article-title":"Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity","volume":"35","author":"Claverys","year":"2000","journal-title":"Mol. Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB108","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/CDLI.8.5.895-898.2001","article-title":"Identification of the psaA gene, coding for pneumococcal surface adhesin A, in viridans group streptococci other than Streptococcus pneumoniae","volume":"8","author":"Jado","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2003.11.038_BIB109","first-page":"623","article-title":"Changes in nasopharyngeal flora during otitis media of childhood","volume":"9","author":"Faden","year":"1990","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.038_BIB110","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/340054","article-title":"Effects of large dosages of amoxicillin\/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media","volume":"34","author":"Ghaffar","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB111","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3476(99)70061-2","article-title":"Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy","volume":"135","author":"Ghaffar","year":"1999","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB112","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/315822","article-title":"Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media","volume":"182","author":"Rapola","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/322763","article-title":"Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media","volume":"184","author":"Rapola","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2003.11.038_BIB114","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/319246","article-title":"Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children","volume":"183","author":"Simell","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.038_BIB115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20011576","article-title":"The immune response to pneumococcal proteins during experimental human carriage","volume":"195","author":"McCool","year":"2002","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB116","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000027672","article-title":"Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media","volume":"61","author":"White","year":"1999","journal-title":"ORL J. Otorhinolaryngol Relat Spec"},{"issue":"4","key":"10.1016\/j.vaccine.2003.11.038_BIB117","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/IAI.66.4.1513-1520.1998","article-title":"Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2","volume":"66","author":"Wortham","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2003.11.038_BIB118","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/318833","article-title":"Protection against bacteremic pneumococcal infection by antibody to pneumolysin","volume":"183","author":"Musher","year":"2001","journal-title":"J. Infect. Dis."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T14:17:12Z","timestamp":1623593832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":118,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X03008387"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}